---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-062618"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T22:07:57.315833+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Sciences receives Nasdaq equity deficiency notice; equity negative $175K

## Summary
- As of March 31, 2024, stockholders' equity was negative $175,385, below the $2.5M minimum for Nasdaq Capital Market.
- Company must submit a compliance plan by July 1, 2024 to regain compliance with Nasdaq Listing Rule 5550(b)(1).
- Nasdaq may grant up to 180-day extension if plan accepted; no guarantee of acceptance or eventual compliance.
- Letter has no immediate effect on listing; company is evaluating options.

## SEC filing metadata
- accession: 0001104659-24-062618
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/0001104659-24-062618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/tm2414775d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-062618
- JSON: https://secwatch.observer/filing/0001104659-24-062618.json
- Plain text: https://secwatch.observer/filing/0001104659-24-062618.txt

## Key facts
- Listing & Compliance Notices
  BNB PLUS CORP. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: (the “Stockholders’ Equity Requirement”). In the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, the Company reported stockholders’ equity of ($175,385), which was below the Stockholders’ Equity Requirement. In accordance with Nasdaq rules, the Company has 45 calendar days, or until July 1, 2024, to submit a plan to the Staff to
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465924062618/0001104659-24-062618-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
